MedTrace Logo

Rhythm Control and Potential Early Surgery for Tricuspid Regurgitation

NCT05045079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-05-21

No results posted yet for this study

Summary

The purpose of this study is to understand the clinical impact of non-surgical and surgical treatment in atrial fibrillation induced tricuspid regurgitation (AFTR).

Conditions

  • Severe Tricuspid Valve Regurgitation (Disorder)

Interventions

PROCEDURE

Inferior Vena Caval (IVC) Occlusion maneuver

During standard of care right heart catheterization (RHC), a second catheter will be inserted next to the catheter that was placed for the RHC in the jugular vein or femoral vein to assess the degree of pericardial restraint from the severe tricuspid regurgitation that may increase left sided filling pressures.

Sponsors & Collaborators

Principal Investigators

  • Yogesh Reddy, MBBS · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2023-08-09
Completion
2023-08-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05045079 on ClinicalTrials.gov